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af kinases relay signals inducing proliferation, dif-
ferentiation, and survival. The Raf-1 isoform has
been extensively studied as the upstream kinase
linking Ras activation to the MEK/ERK module. Recently,
however, genetic experiments have shown that Raf-1
plays an essential role in counteracting apoptosis, and
that it does so independently of its ability to activate MEK.
By conditional gene ablation, we now show that Raf-1 is
required for normal wound healing in vivo and for the
migration of keratinocytes and ﬁbroblasts in vitro. Raf-1–
R
 
deﬁcient cells show a symmetric, contracted appearance,
characterized by cortical actin bundles and by a disor-
dered vimentin cytoskeleton. These defects are due to the
hyperactivity and incorrect localization of the Rho-effector
Rok-
 
 
 
 to the plasma membrane. Raf-1 physically associ-
ates with Rok-
 
 
 
 in wild-type (WT) cells, and reintroduction
of either WT or kinase-dead Raf-1 in knockout ﬁbroblasts
rescues their defects in shape and migration. Thus, Raf-1
plays an essential, kinase-independent function as a spatial
regulator of Rho downstream signaling during migration.
 
Introduction
 
Cell migration is a complex and highly coordinated process
that plays a vital role in many physiological and pathological
situations, such as embryonic development, wound healing,
angiogenesis, and tumor metastasis. Coordinated movement is
the result of the ability of a cell to polarize, extend protrusions
and form adhesions at the leading edge, translocate the cell
body, and finally detach from the substrate at the trailing edge
(Ridley et al., 2003). Cytoskeletal remodeling plays a para-
mount role in migration. In particular, the transition from sta-
tionary to motile cell edges entails the disassembly of peripheral
actin bundles and their replacement by protrusive actin net-
works in lamellipodia (Omelchenko et al., 2003). The small
GTPases of the Rho family are key regulators of these cyto-
skeletal dynamics and of migration. At the leading edge, CDC42
is involved in establishing polarity by recruiting the polarity
protein PAR6 (Macara, 2004), whereas Rac stimulates the for-
mation of lamellipodia through the activation of the Wave
complex (Smith and Li, 2004) and, possibly, via the activation
of the PAK serine/threonine kinases (Bokoch, 2003). The role
of Rho in migration is at least twofold: it induces the assembly
of stable focal adhesions, which may increase adhesion and
therefore decrease motility; and it promotes actomyosin con-
tractility, necessary for the translocation of the cell body. Rho
induces actin reorganization via the downstream effectors Rok-
 
 
 
and mDIA, which cooperate in the formation of stress fibers
(Watanabe et al., 1999), but antagonize each other in Rho-
dependent Rac activation (Tsuji et al., 2002). To establish and
maintain directional movement, a gradient of GTPase activity
must be formed, with CDC42/Rac most active at the leading
edge, Rho at the cell rear and sides. This is thought to be accom-
plished by the regulation and localization of GEF and GAP ac-
tivity (Etienne-Manneville and Hall, 2002; Ridley et al., 2003),
but also via alternative mechanisms, like ubiquitin-mediated
Rho degradation at the leading edge (Wang et al., 2003).
The Raf serine/threonine kinases relay signals inducing
cell proliferation, differentiation, and survival. Raf-1 has been
most intensively studied as the downstream effector linking
Ras activation to the MEK/ERK module. However, among the
three Raf kinases (A-Raf, B-Raf, and Raf-1) B-Raf is the most
efficient in interacting with Ras (Marais et al., 1997; Weber et
al., 2000) and in activating the MEK/ERK module (Pritchard et
al., 1995, 2004; Wojnowski et al., 2000). In addition, gene
ablation experiments have shown that ERK activation and pro-
liferation proceed normally in the absence of Raf-1, whereas
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Raf-1 is required to restrain apoptosis during embryonic devel-
opment (Huser et al., 2001; Mikula et al., 2001). Raf-1 appears
to counteract the activation of caspases, proteases which dis-
mantle the cell during apoptosis but also play a role in the ter-
minal differentiation of keratinocytes and erythroblasts (Al-
geciras-Schimnich et al., 2002). Raf-1 can restrain caspase
activity both in the context of apoptosis induced by specific
stimuli (Jesenberger et al., 2001; Mikula et al., 2001), and in
the context of erythroblast differentiation (Kolbus et al., 2002).
The role of Raf-1 in migration in vivo has never been ad-
dressed. However, Raf-1 has been implicated in the control of
motility in COS cells downstream of the small GTPase Rac
(Leng et al., 1999). Rac can control Raf-1 activation via its
downstream target PAK, which phosphorylates serine 338 on
Raf-1 (King et al., 1998; Li et al., 2001; Zang et al., 2002). A
role for Rho in Raf-1 activation has also been described, but the
effectors involved are unknown (Li et al., 2001).
Epidermal development, homeostasis, and repair are
complex processes requiring the exact orchestration of cell pro-
liferation, migration, and differentiation. Several of the signals
essential for epidermal development and repair, most promi-
nently those transduced by the EGFR and by integrins (Fuchs
and Raghavan, 2002; Watt, 2002), reportedly activate Raf-1
(Howe et al., 2002). In turn, Raf-1 regulates the production of
EGFR ligands by epidermal cells (Schulze et al., 2001) as well
as integrin expression (Woods et al., 2001) and their affinity
for the matrix (Hughes et al., 1997). In addition, activation of
the Ras–Raf–ERK pathway has been found associated with
skin proliferation in physiological as well as pathological con-
ditions (Haase et al., 2001; Vasioukhin et al., 2001; Dajee et
al., 2002). In contrast, others have reported that constitutive
Ras/Raf activation arrests growth and induces features of ter-
minal differentiation in cultured murine keratinocytes (Lin and
Lowe, 2001; Roper et al., 2001). To elucidate the role of Raf-1
in epidermis, we performed tissue-restricted ablation of the
gene by generating mice carrying a homozygous 
 
c-raf-1
 
flox/flox
 
(
 
f/f
 
) allele (Jesenberger et al., 2001) and a Cre transgene driven
by the Keratin 5 promoter, active in the basal epidermal layer
and follicular keratinocytes (Tarutani et al., 1997).
We find that Raf-1 is dispensable for epidermal devel-
opment and homeostasis, but is required for efficient wound
healing. This phenotype is due to a cell-autonomous defect in
migration, which can be observed in Raf-1 knockout (KO) kera-
tinocytes, but also in fibroblasts. In both cell types, the Rho ef-
fector Rok-
 
 
 
 is hyperactive and constitutively localized at the
cell membrane. The migration defect can be corrected by chem-
ical inhibition of Rok-
 
 
 
 or by expression of kinase-dead (KD)
Rok-
 
 
 
, as well as by the reintroduction of a KD Raf-1 in the KO
cells. These data uncover a kinase-independent, essential func-
tion of Raf-1 in the spatial control of Rho downstream signaling.
 
Results
 
Raf-1 is required for efficient migration 
in vivo and in vitro
 
We have used a Cre transgene expressed in the basal epidermal
layer and follicular keratinocytes (Tarutani et al., 1997), to induce
epidermis-specific ablation of the 
 
c-raf-1
 
 gene. Primary kerati-
nocytes derived from mice carrying an homozygous 
 
c-raf-1
 
flox/flox
 
(
 
f/f
 
) allele (Jesenberger et al., 2001) and the K5Cre transgene
(
 
c-raf-1
 
 
 
/
 
 
 
ep
 
, deleted in epidermis) showed complete conversion of
the 
 
c-raf-1
 
flox
 
 to the 
 
c-raf-1
 
 
 
 allele by PCR and lacked Raf-1 pro-
tein (Fig. 1, A and B). 
 
c-raf-1
 
 
 
/
 
 
 
ep
 
 mice were viable, fertile, and
healthy. At 4 wk old, they displayed curled whiskers and a wavy
fur (Fig. 1 C), a phenotype lost after the first hair cycle. The archi-
tecture of the epidermis (Fig. 1 D) as well as the expression of
basal keratin and differentiation markers in the epidermis and hair
follicles was indistinguishable in 
 
c-raf-1
 
 
 
/
 
 
 
ep
 
 mice and control lit-
termates (not depicted). Thus, Raf-1 is not essential in epidermal
development and homeostasis. Raf-1 ablation, however, mark-
edly affected wound healing. Control mice closed and reepithe-
lialized full thickness wounds (6-mm 
 
 
 
) by day 9 after wound-
ing, whereas 
 
 
 
40% of the wound was still open in 
 
c-raf-1
 
 
 
/
 
 
 
ep
 
mice at this time (not depicted). The wounds were not yet closed
on day 12, when control mice had already completed both reepi-
thelialization and clearance of cell debris underneath the wound
crust (Fig. 2 A). 
 
c-raf-1
 
 
 
/
 
 
 
ep
 
 mice healed the wounds 4–5 d later,
and the healed skin was indistinguishable from that of 
 
f/f
 
 mice
(not depicted). The secondary responses of dermal components
(granulation, inflammation, and neo-vascularization) were not af-
fected by Raf-1 ablation in keratinocytes. The number of prolifer-
ating keratinocytes around the wound site was similarly unaf-
fected (31 
 
 
 
 10.8 Ki67
 
 
 
 cells in 
 
f/f
 
, 32.5 
 
 
 
 8.8 in 
 
 
 
/
 
 
 
ep
 
), and
TUNEL staining of the migrating epithelial sheets did not show
any apoptotic cells in 
 
c-raf-1
 
 
 
/
 
 
 
ep
 
 or control wounds (not de-
picted). Thus, lack of Raf-1 significantly delayed wound healing
in the absence of proliferation or survival defects, suggesting that
Raf-1 might be needed for keratinocyte migration.
Indeed, in a modified Boyden chamber assay, keratinocyte
growth medium (KGM), EGF, or KGF efficiently promoted mi-
Figure 1. Keratinocyte-specific disruption of c-raf-1 by the Cre-loxP system.
(A) PCR genotyping of keratinocytes (KC) and tail genomic DNA prepara-
tions (T). M, marker. (B) Lack of Raf-1 protein in c-raf-1
 / ep keratinocytes.
Keratinocytes isolated from six independent animals were lysed and sub-
jected to Western blotting with an  -Raf kinase domain mAb, which rec-
ognizes all three Raf kinases. The genotype of the mice is indicated at the
bottom of the panel. The band corresponding to Raf-1 is absent in K5-Cre
 
cultures. (C) c-raf-1
 / ep mice display waved fur during the first hair cycle.
A 4-wk old f/f and a c-raf-1
 / ep littermate are shown. (D) Normal epidermal
architecture in c-raf-1
 / ep newborn mice. Paraffin sections from f/f or
c-raf-1
 / ep skin were stained with hematoxylin/eosin. 
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gration of 
 
f/f 
 
keratinocytes, but Raf-1–deficient keratinocytes
displayed a cell-autonomous defect in migration (Fig. 2 B)
which most likely accounts for the delay in wound healing ob-
served in vivo. Additionally, Raf-1 KO keratinocytes performed
less well than wild-type (WT) cells in a short-term (15 min) ad-
hesion assay on a number of substrates (Fig. 2 C), suggesting a
defect in spreading. Consistent with this, 
 
c-raf-1
 
 
 
/
 
 
 
ep
 
 cells ad-
hered on fibronectin for 24 h displayed a symmetric, contracted
shape and a characteristic, tight ring of cortical actin (Fig. 2 D).
The defects in motility, adhesion, and shape were even
more dramatic in Raf-1 KO fibroblasts. These performed con-
sistently worse than WT cells in an in vitro wound healing as-
say, in the presence or absence of motogenic signals (Fig. 3 A),
and in a short-term adhesion assay, likely due to a delay in
spreading (Fig. 3 B). Raf-1 KO fibroblasts also displayed a
symmetric, contracted morphology. Longitudinal stress fibers
were markedly reduced, and the actin was organized in tight
cortical bundles (Fig. 3 C) reminiscent of those observed in
Raf-1 KO keratinocytes. This redistribution of actin fibers to
the cell cortex was not accompanied by an alteration in actin
treadmilling, as the levels of F- and G-actin detected in WT and
KO fibroblasts were comparable (not depicted). Thus, cell-
autonomous defects in shape, spreading, and migration were a
common feature of Raf-1 KO keratinocytes and fibroblasts.
 
Rho signaling is deregulated in Raf-1 KO 
cells
 
The small GTPase Rho controls cell shape and motility by in-
creasing intracellular tension and contractility (Etienne-Manne-
ville and Hall, 2002). The shape of Raf-1 KO cells, the de-
fects in spreading, and their failure to migrate all suggested a
possible hyperactivation of Rho. Rho downstream targets such
as the regulatory subunit of the myosin light chain phosphatase
(MYPT1; pT696), ezrin (pT567), paxillin (pY118), and FAK
(pY397; Fig. 4 A) were hyperphosphorylated in KO cells. Yet,
basal Rho activity was not elevated in Raf-1 KO cells, and mi-
gration induced Rho-activation was in fact delayed (Fig. 4 A).
Activated paxillin (Tsubouchi et al., 2002) and ezrin (Speck et
al., 2003) can reportedly inhibit Rho activity, and are likely re-
sponsible for the decreased Rho stimulation. Phosphorylation
(and inactivation) of MYPT1 results in the phosphorylation of
myosin light chain (Kimura et al., 1996) and ezrin (Fukata et al.,
1998). Ezrin phosphorylation, in turn, relieves intramolecu-
lar  inhibition and enables ezrin to act as an actin filament/
plasma membrane cross-linker (Bretscher et al., 2002). Together,
MYPT1 and ezrin phosphorylation explain the contracted ap-
pearance and the tight cortical actin network observed in KO
cells. Indeed, expression of a dominant-negative ezrin mutant
(DN-Ez-eG, ezrin
 
1-310
 
 fused to eGFP) corrects these defects
(Fig. 4 B, compare transfected and untransfected cell). The Rho
effector Rok-
 
 
 
 phosphorylates MYPT1 directly (Kawano et al.,
1999) and regulates ezrin both by direct phosphorylation and by
inactivation of MYPT1 (Fukata et al., 1998; Matsui et al.,
1998), and further induces paxillin and FAK hyperphosphoryla-
tion (Sinnett-Smith et al., 2001; Tsuji et al., 2002). It also phos-
phorylates vimentin, thereby causing the collapse of the vimen-
tin filaments into a juxtanuclear aggregate (Sin et al., 1998), an
additional characteristic feature of Raf-1 KO fibroblasts (see
Figure 2. Raf-1 ablation affects wound healing in vivo and keratinocytes motility, adhesion, and shape in vitro. (A) Hematoxylin/eosin-stained full thickness
skin section, 12 d after wounding. The wound margins (arrows) have not yet met in the c-raf-1
 / ep animals. C, crust; E, newly formed epidermis; D, dermis.
(B) Impaired migration in Raf-1 KO keratinocytes. Migration was assayed in a modified Boyden chamber assay using KGM (10 h), EGF (25 ng/ml, 15 h),
or KGF (20 ng/ml, 15 h) as chemoattractants. (C) The percentage of cells adhering to different ECM components was determined in a 15-min adhesion
assay (Fn, fibronectin; Ln, laminin; C1 and C4, collagens I and IV). Integrin-independent adhesion on BSA-coated surfaces was subtracted from the values
plotted. Values are means ( SD, vertical bars) of three individual experiments. (D) Morphology of keratinocytes stained to visualize the actin cytoskeleton
(rhodamine-conjugated phalloidin). Bar, 15  m. 
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Fig. 5 C). Thus, the defects observed in KO cells were consis-
tent with deregulation of Rok-
 
 
 
 enzymatic activity.
The expression of Rok-
 
 
 
 was slightly (1.5/2-fold) re-
duced in Raf-1 KO cells (Fig. 4, A and G). However, both
basal and serum-stimulated Rok-
 
 
 
 activity was elevated in
Raf-1 KO fibroblasts (Fig. 4 C). ADP-ribosylation of the Rho
GTPase by cell-permeant C3 exoenzyme (Barth et al., 1998)
reduced the hyperphosphorylation of ezrin detected in Raf-1
KO fibroblasts, indicating that Rok-
 
 
 
 activation still required
basal Rho activity in these cells (Fig. 4 D).
To assess whether Rok-
 
 
 
 deregulation caused the defects
in shape and migration, Raf-1 KO cells were treated with the
Rok inhibitor Y-27632. The inhibitor corrected MYPT1 and
paxillin hyperphosphorylation (Fig. 4 E) as well as the redistri-
bution of vimentin to a perinuclear location in KO fibroblasts
(Fig. 5 C), and significantly improved the migratory ability and
shape of Raf-1 KO fibroblasts (Fig. 4 F and Fig. 5 C) and kera-
tinocytes (Fig. 4 H; and not depicted). Transfection with KD
Rok-
 
 
 
 had an even more profound impact than Y-27632 on both
WT and KO fibroblasts, ruling out possible Rok-
 
 
 
–independent
effects of the inhibitor. Raf-1 KO fibroblasts transfected with
KD Rok-
 
 
 
 lost their characteristic tight cortical actin bundles
and contracted shape, formed stress fibers and vimentin fila-
ments similar to those of untreated WT fibroblasts (Fig. 5 D),
and migrated as efficiently as untransfected WT cells in a tran-
swell assay (Fig. 5 E). In contrast, the expression of KD Rok-
 
 
 
had a deleterious effect on both the shape (Fig. 5 D) and the mi-
gratory ability (Fig. 5 E) of WT cells. This is in line with a re-
quirement for Rok-
 
 
 
 in the maintenance of cell shape and mi-
gration of normal fibroblasts. The opposite effects of KD Rok-
 
 
 
on WT and KO cells strongly argue in favor of Rok-
 
 
 
 hyperac-
tivity as the molecular basis of the defects of Raf-1 KO cells.
 
The physical presence of Raf-1, but not 
its kinase activity, are required for 
efficient migration
 
The data above support the hypothesis that Raf-1 restrains Rok-
 
 
 
signaling during migration. As Raf-1 was activated during
early in vitro wound healing, albeit not to the extent induced by
growth factor stimulation (Fig. 5 A), we investigated whether
kinase activity was necessary for this function by generating sta-
ble KO fibroblast lines expressing full-length kinase-competent
(KC) Raf-1 or a KD version of the protein at nearly endogenous
levels (Fig. 5 B). Vector-transfected clones (V) were morpho-
logically indistinguishable from Raf-1 KO fibroblasts (Fig. 5
C), and migrated just as poorly (Fig. 5 B). Both KC and KD
Raf-1 rescued cell morphology (Fig. 5 C) as well as the ability
of cells to adhere (not depicted) and to migrate in the in vitro
wound assay (Fig. 5 B). Re-expression of both KC and KD Raf-1
also rescued vimentin filaments (Fig. 5 C). Thus, the physical
presence of Raf-1, but not its kinase activity, is required to regu-
late Rho downstream signaling and to support migration.
 
Raf-1 associates physically with Rok-
 
 
 
 
and controls its localization within the cell
 
We next tested whether Raf-1 associates physically with Rok-
 
 
 
.
Indeed, Rok-
 
 
 
, but not the closely related kinase Rok-
 
 
 
 (not de-
picted), was present in increasing amounts in endogenous Raf-1
immunoprecipitates obtained from migrating fibroblasts (Fig. 6 A).
Rok-
 
 
 
 could be coimmunoprecipitated with an antibody recog-
nizing the COOH terminus of Raf-1, but not its NH
 
2
 
 terminus,
suggesting that the latter may be involved in the interaction with
Rok-
 
 
 
. To confirm this and to test whether the association
could be detected by using an antibody directed against Rok-
 
 
 
instead of Raf-1, we coexpressed full-length Raf-1 as well as
the truncated NH
 
2
 
-terminal (
 
 
 
C) and COOH-terminal (
 
 
 
N) do-
main of Raf-1 with HA-tagged Rok-
 
 
 
 in COS-1 cells. HA im-
munoprecipitates from subconfluent COS-1 cells contained
full-length and 
 
 
 
C Raf-1, but not the form lacking the NH
 
2
 
 ter-
minus (Fig. 6 B). Thus, Raf-1 associates physically with Rok-
 
 
 
via its NH2 terminus. Whether Raf-1 binds Rok-  directly, or
whether a bridging molecule is involved in the interaction,
is presently unknown. Raf-1 and Rok-  decorated elongated
structures previously identified as vimentin filaments (not de-
picted; Sin et al., 1998; Janosch et al., 2000). Raf-1 colocalized
with Rok-  in both nonmigrating (Fig. 6 C) and migrating WT
cells (Fig. 6 D), although Raf-1 distribution was not restricted to
the filaments. In migrating cells, both kinases displayed a polar-
ized pattern, being mainly concentrated around the nucleus, in
the trailing edge and along the lateral margins of the cells, and
essentially excluded from the protrusions.
Lack of Raf-1 induced profound changes in the subcellu-
lar distribution of Rok- . In KO fibroblasts Rok-  was no
longer associated with the vimentin cytoskeleton, but was
rather localized at the membrane at the cell front. Re-expres-
sion of either KC or KD Raf-1 restored this defect (Fig. 7 A).
Figure 3. Raf-1 ablation affects fibroblasts motility, adhesion, and shape in vitro. (A) Fibroblast motility assayed by in vitro wound healing in serum-free medium.
Wound closure was photographed after 18 h. Arrows, wound margins at time 0. The percent wound closure at different times is plotted on the left.
The values represent the means ( SD, vertical bars) of three independent experiments. (B) The percentage of cells adhering to different ECM components
was determined in a 30-min adhesion assay as described in the legend to Fig. 2. Integrin-independent adhesion on BSA-coated surfaces was subtracted from
the values plotted. Values are means ( SD, vertical bars) of five individual experiments. (C) Morphology of fibroblasts stained to visualize the actin cytoskeleton.RAF-1 AND MIGRATION • EHRENREITER ET AL. 959
Similarly, Rok-  was often observed at the membrane in KO
keratinocytes, whereas in WT cells the staining was essentially
excluded from this location (Fig. 7 B).
Discussion
The data described above assign a novel function to Raf-1 in
migration. Raf-1 KO fibroblasts and keratinocytes are defec-
tive in adhesion and motility, whereby the latter phenotype is
more severe and can be observed in vivo as delayed kerati-
nocyte migration during wound healing. The basis of these
phenotypes is the deregulation of Rok- , which interacts phys-
ically with Raf-1 in WT cells. Thus, Raf-1 operates as a regula-
tor of Rho-downstream signaling.
Role of Raf-1 in the epidermis
The epidermis of c-raf-1
 / ep mice shows normal thickness and
architecture indicating that, in vivo, Raf-1 is not an essential
component of the pathways mediating skin proliferation and
differentiation. Consistently, the phosphorylation of ERK, which
has been established as an important player in skin proliferation
(Haase et al., 2001; Vasioukhin et al., 2001; Dajee et al., 2002)
and as the main mediator of the transcriptional responses in-
duced by Raf-1 (Schulze et al., 2004), is not reduced in Raf-1
KO keratinocytes. Rok- , which we find mislocalized and acti-
vated in Raf-1 KO cells, actually promotes keratinocyte differ-
entiation in vitro when overexpressed in a constitutively active
form (McMullan et al., 2003). Raf-1 KO keratinocytes, how-
ever, are not more differentiated than WT cells as determined
by a number of differentiation markers, including involucrin
and suprabasal keratins. Therefore, the degree of Rok-  activa-
tion observed in Raf-1 KO cells is not enough to drive sponta-
neous differentiation in vitro or in vivo. The impaired migration
of Raf-1 KO keratinocytes and the delayed wound healing ob-
served in the c-raf-1
 / ep mice are so far the only significant de-
fects resulting from epidermis-restricted Raf-1 ablation.
Raf-1 regulates Rho signaling and 
migration
The results discussed above show that Raf-1 regulates Rho sig-
naling at the level of Rok-  localization and activation. We hy-
pothesize that in WT cells, the formation of a Raf-1–Rok- 
Figure 4. The defects in shape and migration of
Raf-1 KO cells correlate with Rok-  deregulation.
(A) Lysates collected from migrating fibroblasts
were assayed for Rho activity as described in
Materials and methods. The phosphorylation
of MYPT1, ezrin, paxillin, FAK, ERK, and the
expression of Rok-  and tubulin (loading control)
was determined by immunoblotting. (B) Mor-
phology of KO cells expressing eGFP (eG) or
eGFP-ezrin
1-310 (DN-Ez-eG) stained to visualize
the actin cytoskeleton. (C) Rok-  kinase activity
is elevated in Raf-1 KO fibroblasts. Rok- 
immunoprecipitates were prepared from un-
treated (Unt) and serum-stimulated (FCS, 10%,
1 h) WT and KO fibroblasts. Rok-  kinase
activity was assayed as the ability of the im-
munoprecipitates to phosphorylate recombi-
nant MYPT1. The results plotted are the mean
( SD) of three independent experiments, nor-
malized for the amount of Rok-  present in the
immunoprecipitates and expressed as percent-
age of the activity present in the immunopre-
cipitates from unstimulated WT cells. (D) Basal
Rho activity is necessary to sustain Rok-  activity
in WT and KO cells. WT and KO cells were
treated for 3 h with a combination of clostridial
toxins to ADP-ribosylate Rho. Ezrin (pT567),
Rho, and ADP-ribosylated Rho (Rho*, migrating
as a smear above the Rho band) were de-
tected by immunoblotting. (E) The Rok inhibi-
tor Y-27632 reverts hyperphosphorylation of
MYPT1 and paxillin in Raf-1 KO fibroblasts.
Lysates were collected from migrating cells
pretreated or not with Y-27632 (10  M, 4 h).
A Rac immunoblot is shown as a loading
control.  (F) Y-27632 improves morphology
and migration of KO fibroblasts. Left panel,
phase contrast images of WT and KO fibro-
blasts left untreated or treated with Y-27632
for 20 min. (Right) Migration of Y-27632–
treated or –untreated WT and KO fibroblasts
in a wound closure assay (20 h). Values are
means    SD of three individual samples.
(G) Lysates collected from subconfluent keratinocytes. Protein expression and phosphorylation was determined as in A, except that Raf-1 was detected with an an-
tibody specific for the Raf-1 NH2 terminus. Loading control, Keratin 5. (H) Y-27632 improves migration of KO keratinocytes. Y-27632–treated and –untreated
cells were allowed to migrate for 6 h in a modified Boyden chamber assay using KGM as a chemoattractant. Values are means   SD of three individual samples.JCB • VOLUME 168 • NUMBER 6 • 2005 960
complex limits Rok-  activation and its presence at the leading
edge, thereby releasing tension and allowing lamellipodia for-
mation. Rok-  activation by Rho involves the reorganization of
the vimentin network, which collapses in a juxtanuclear aggre-
gate and releases Rok- . Rok-  then translocates to the cell pe-
riphery, and this correlates with increased contractility. Rok- 
itself phosphorylates vimentin. This phosphorylation decreases
the affinity of vimentin for Rok-  and contributes to the col-
lapse of the intermediate filaments. Thus, either autoinduction
or a positive feedback loop are apparently involved in Rok- 
activation (Sin et al., 1998). How could Raf-1 antagonize this
process? At least two possibilities can be envisioned: first, the
presence of Raf-1 may increase the affinity of Rok-  for vi-
mentin, thereby limiting Rok-  membrane translocation and
activation. Alternatively, Raf-1 might have a more direct role
and inhibit Rok-  kinase activity. Both Raf-1 (Cutler et al.,
1998) and Rok-  (Amano et al., 1999) are regulated by in-
tramolecular inhibition. In both cases, an autoregulatory region
(the NH2-terminal domain in Raf-1, the COOH-terminal do-
main in Rok- ) binds to the kinase domain and inhibits activ-
ity. Upstream activators are thought to disrupt the interaction
between the kinase domain and the autoinhibitory region to
give rise to an active kinase. Remarkably, the autoregulatory
domains of the two kinases contain cysteine-rich, highly ho-
Figure 5. Raf-1, but not its kinase activity, is required to maintain cell shape, adhesion, and motility in fibroblasts. (A) Migration stimulates Raf-1 kinase activity.
Raf-1 activation was measured in an immunocomplex kinase assay. Immunoprecipitates from WT fibroblasts treated with EGF (33 nM, 10 min) were used
as an activation control. The Western blot shows the amount of Raf-1 in the immunoprecipitates. (B; top) Reexpression of KC or KD Raf-1 rescues the migratory
defect of Raf-1 KO fibroblasts in a wound healing assay (20 h). (Bottom) Raf-1 expression in whole cell lysates from WT and KO fibroblasts and from
stable clones of KO cells expressing either KC (KC1, KC3) or KD Raf-1 (KD9, KD11). V, empty vector. Values represent the mean   SD of triplicate samples.
(C) KC and KD Raf-1 as well as Y-27632 and (D) KD Rok-  rescue the actin and vimentin cytoskeleton defects of Raf-1 KO fibroblasts plated on fibronectin.
(Top) Actin visualized with rhodamine-conjugated phalloidin. (Bottom) Staining with  -vimentin antibodies. In D, expression of KD Rok-  (HA-Rok-  KD)
in WT and KO cells was verified by staining with an anti-HA antibody (HA). Asterisks represent nontransfected cells. (E) Expression of KD Rok-  improves
migration of KO cells. WT and KO cells transfected with KD Rok-  (HA-Rok-  KD) or with the corresponding empty vector (HA-V) were allowed to migrate
for 2.5 h in a modified Boyden chamber assay using 10% FCS as a chemoattractant. Unt, untransfected cells. The results represent the mean of four inde-
pendent values and are expressed as percentage of cells that migrated through the pores of the polycarbonate membrane. For transfected cells, expres-
sion of the construct was visualized by immunofluorescence and the result were expressed as percentage of transfected cells migrated. Values represent
the mean   SD of quadruplicate samples.RAF-1 AND MIGRATION • EHRENREITER ET AL. 961
mologous pleckstrin-homology domains (Leung et al., 1996). It
is conceivable that Raf-1 may bind to the Rok-  kinase domain
once autoinhibition has been released, thereby keeping Rok- 
activation in check. Consistent with this model, Rok-  activa-
tion in Raf-1 KO cells still depends on a functional Rho GTP-
ase (Fig. 4 D), and Raf-1 binds to Rok-  via its NH2-terminal
regulatory domain (Fig. 6 B). In addition, we have recently
demonstrated that transfection with the isolated NH2-terminal
domain of Raf-1 is sufficient to rescue the defects of the Raf-1
KO fibroblasts (unpublished data).
Either of the proposed mechanisms may involve phos-
phorylation of one or both proteins by upstream kinases. In this
context, we have shown that the kinase activity of Raf-1 is
moderately stimulated during in vitro wound healing. The same
phosphorylation events that stimulate Raf-1 MEK-kinase activ-
ity in vitro by relieving autoinhibition might render the NH2-
terminal domain of Raf-1 available to interact with Rok- ; al-
ternatively, they may determine the subcellular localization of
the complex. At present, we favor the former hypothesis, as
Raf-1 and Rok-  colocalize on the intermediate filaments even
in nonmigrating, starved cells. In either case, however, the KD
mutant would be phosphorylated by upstream kinases in a
manner similar to the WT and hence rescue adhesion/migration.
We are currently determining the exact requirements for Raf-
1–Rok-  interaction by mutational analysis.
The discovery of a kinase-independent function of Raf-1
in the control of cell polarity and migration is surprising given
the number of Raf-1 phosphorylation targets of this kinase that
affect these processes. Activated MEK/ERK, the traditional
target of the Raf-1 kinase, plays an important role in the main-
tenance of cell shape and in migration (Klemke et al., 1997;
Cheresh et al., 1999; Glading et al., 2001), and can reduce Rok
expression and activation (Sahai et al., 2001; Pawlak and Helf-
man, 2002; Vial et al., 2003). However, as previously de-
scribed for growth factor–induced activation (Huser et al.,
2001; Mikula et al., 2001), Raf-1 is dispensable for ERK ac-
tivation during migration. Consistently, B-Raf and MEKK1
have been identified as the upstream kinases required for ERK
activation in migrating fibroblasts (Cuevas et al., 2003; Prit-
chard et al., 2004). Interestingly, the phenotype of the MEKK-1
and of the B-Raf KO are opposite: in the MEKK-1 KO, lack of
ERK activation causes defective rear-end detachment, due to
the lack of calpain activation and focal adhesion turnover (Cue-
vas et al., 2003). This results in reduced migration. In contrast,
B-Raf KO fibroblasts are more spread, and migrate faster, than
WT cells, due to increased stress fibers depolymerization (Prit-
chard et al., 2004). Thus, ERK appears to accomplish distinct
functions during migration, that can be evidenced by deleting
specific upstream kinases.
A further Raf-1 target implicated in the regulation of mo-
tility is the phosphatase MYPT1, which is inactivated by Raf-1–
mediated phosphorylation (Broustas et al., 2002). MYPT1 de-
phosphorylates myosin light chain, and MYPT1 deregulation
would ultimately lead to decreased cell contractility. The phe-
notype of the KO cells, therefore, is entirely inconsistent with
MYPT1 deregulation. Lack of Raf-1 in this context is likely
compensated by the hyperactivation of Rok- , itself able to in-
hibit MYPT1 by phosphorylation (Kimura et al., 1996), and to
phosphorylate myosin B light chain (Amano et al., 1996).
Finally, the discovery that lack of Raf-1 causes deregula-
tion of Rok-  activity has had a major impact on the investiga-
tion of the anti-apoptotic function of Raf-1 and of the role of
Figure 6. Rok-  associates with Raf-1. (A) WT fibroblast
monolayers were induced to migrate and lysates were col-
lected at different times after wounding. Endogenous Raf-1
immunoprecipitates obtained with a pAb against a COOH-
terminal Raf-1 epitope (CTLTTSPRLPVF) were analyzed by
immunoblotting to visualize the presence of Rok-  and Raf-1.
(B) COS-1 cells were cotransfected with HA-Rok-  and full-
length Raf-1 as well as the Raf-1 NH2-terminal ( C) or
COOH-terminal ( N) domain. HA immunoprecipitates were
prepared from subconfluent cells 48 h after transfection and
analyzed by immunoblotting. (C and D) Raf-1 and Rok- 
colocalize in nonmigrating (C) and migrating (D) fibroblasts.
(Bottom; left) Raf-1; right, Rok- . (Top) merge.JCB • VOLUME 168 • NUMBER 6 • 2005 962
this kinase in embryonic development. We could recently show
that hyperphosphorylation and deregulation of ezrin secondary
to Rok-  activation are responsible for the selective up-regula-
tion of the death receptor Fas in Raf-1 KO fibroblasts in vitro
and liver cells in vivo. By genetically reducing Fas expression,
we could further show that this up-regulation is responsible for
fetal liver apoptosis and for the embryonic death of Raf-1 KO
embryos (unpublished data). These data indicate that, whereas
the presence of enzymes with similar or identical substrate
specificity may enable cells to cope with the absence of the cat-
alytic function of a specific kinase, KO experiments like ours
are more likely to uncover specialized essential functions con-
nected with protein–protein interactions.
Materials and methods
Generation of c-raf-1
 / ep mice
Mice carrying a floxed c-raf-1 allele were crossed to transgenic mice ex-
pressing the Cre recombinase under the control of the keratinocyte specific
Keratin 5 promoter (K5Cre2; Tarutani et al., 1997) to obtain c-raf-1
 / ep
animals. Allele-specific PCR genotyping was performed as described pre-
viously (Jesenberger et al., 2001).
Histology, immunohistochemistry, and TUNEL assay
Tissues from newborn or adult mice were fixed overnight in buffered 4%
PFA (in PBS, pH 7) at 4 C, dehydrated, and embedded in paraffin. 5- m
sections were stained with hematoxylin and eosin. Immunohistochemistry
staining for Ki67 (Novocastra), Keratin 5, and Involucrin (BaBCo) were
performed using the ABC staining kit (Vector Laboratories) according to
the manufacturer’s recommendations. TUNEL staining was performed us-
ing the in situ cell death detection kit (Roche).
In vivo wound healing assay
These experiments were performed in strict adherence to institutional
guidelines for minimizing distress in experimental animals. Full-thickness
skin excisions were made using a biopsy punch of 6-mm diam on the back
of 8–10-wk-old mice anesthetized with Ketamine/Xylazine. Wound heal-
ing was monitored histologically by fixing the wounded skin after 2, 5, 8,
10, 12, and 16 d after wounding (n   5 for each time point).
Cell isolation, culture, infection, and transfection
Primary mouse keratinocytes from 3-d-old mice were isolated as de-
scribed previously (Hennings, 1994) and cultured in KGM (Ca
2 -free;
CLONTECH Laboratories, Inc.) supplemented with 2% chelated FCS
(Carroll et al., 1995), 0.4  g/ml hydrocortisone, 5  g/ml insulin, 5
 g/ml transferrin (Sigma-Aldrich), 10 ng/ml EGF, 60  g/ml bovine pi-
tuitary extract, gentamycin (50  g/ml), and 100 U/ml nystatin (Roche).
The final concentration of Ca
2  of the KGM was 0.05 mM. COS-1 cells
and 3T3-like fibroblast cell lines derived from E12.5 Raf-1 KO and WT
embryos (Mikula et al., 2001) were cultured in DME supplemented with
10% FCS. Stable cell clones expressing KC and KD Raf-1 were obtained
by infecting Raf-1 KO fibroblasts with retroviruses containing pMNC-
Raf-1 (KC) and pMNC-Raf-1K375W (KD; a gift from W. Kolch, Beatson
Institute for Cancer Research, Glasgow, UK; Kolch et al., 1991). Tran-
sient transfections were performed using lipofectamine according to
the manufacturer’s instructions. COS-1 cells were transfected with HA-
tagged Rok-  (Chen et al., 2002) in combination with full-length Raf-1,
the Raf-1 NH2-terminal domain (aa 1–257,  C) or the Raf-1 COOH-ter-
minal domain ( N, internal deletion of aa 26–302; Bruder et al.,
1992). Fibroblasts were transfected with KD, dominant negative Rok- 
(pXJ40-HA-Rok- -KD; Leung et al., 1996), and DN-Ez-eG (a gift from R.
Lamb, Institute of Cancer Research, London, UK) or the corresponding
empty vectors.
Adhesion and migration assays
The attachment assays were performed using the Cytomatrix kit (CHEMI-
CON International, Inc.) according to the manufacturer’s instructions. For
the in vitro wounding assay, starved cells were pretreated with 10  g/ml
mitomycin C for 2 h to block proliferation and a cell-free area was cre-
ated by scratching the monolayer with a 200- l pipette tip. Cell migra-
tion into the wound area was monitored in serum-free medium or in the
presence of 30 ng/ml EGF or 10% FCS. Photographs were taken using a
phase-contrast microscope (DIAPHOT 300; Nikon). In selected experi-
ments, the ROK-  inhibitor Y-27632 (10  M; Calbiochem) was added to
the monolayers 20 min before in vitro wounding. For the modified Boy-
den chamber migration assay, equal numbers of cells suspended in se-
rum-free medium were plated in the top chamber and allowed to migrate
through the pores (8  m) of a polycarbonate membrane toward a
chemoattractant (KGM, EGF, KGF, or FCS) placed in the bottom cham-
ber. Cells on the underside of the membrane were fixed, stained with
10% crystal violet and counted (5–7 random fields/membrane) by two in-
dependent investigators. In the assays using HA-Rok- -KD–transfected fi-
broblasts, total cells were visualized by staining the filters with rhoda-
mine-conjugated phalloidin (Molecular Probes), whereas transfected cells
were detected by immunofluorescence using a monoclonal  -HA anti-
body (12CA5).
Immunoprecipitation, kinase assays, and Western blot analysis
Cells lysis, Western blotting, Raf-1 immunoprecipitation, and kinase assay
were performed as described previously (Mikula et al., 2001). To assay
Rok-  kinase activity, Rok-  was immunoprecipitated from 150  g of ly-
sate using an antibody against the NH2-terminal domain of the protein
(Upstate Biotechnology). The immunoprecipitates were incubated (15 min,
30 C) with 1  g of recombinant MYPT1 (Upstate Biotechnology). The su-
pernatant of the reactions was loaded on a gel and the phosphorylation of
MYPT1 analyzed on a PhosphorImager.
15–50  g of lysate were used in Western blotting. The following
antibodies were used for immunoblotting:  -Raf kinase domain (Fig. 1 B;
Kolch et al., 1990),  –Raf-1 (NH2 terminus; Fig. 4 G),  -pFAK (pY397),
 –Rok-  and  -pERK (BD Biosciences),  -pPaxillin (pY118) and  -pEzrin/
Moesin/Radixin (pT567; Cell Signaling),  -Rac1 and  -pMYPT1 (pT696;
Upstate Biotechnology), and  -tubulin (Sigma-Aldrich).
Figure 7. Raf-1, but not its kinase activity, is required for correct Rok- 
localization. (A and B) Rok-  is not excluded from cell protrusions in
migrating Raf-1 KO fibroblasts (A) and keratinocytes (B). The defect is
corrected in fibroblasts expressing KC or KD Raf-1, but not in those trans-
fected with empty vector (V; A). Rok-  staining was visualized in perme-
abilized fibroblasts by confocal microscopy (A); in subconfluent kerati-
nocytes by epifluorescence (B). The dotted lines in panel f/f represent
the contours of the keratinocytes. Arrows in A and B point to Rok- 
membrane staining.RAF-1 AND MIGRATION • EHRENREITER ET AL. 963
Immunofluorescence
Cells plated on fibronectin (Invitrogen) were permeabilized (0.01% Triton
X-100), fixed in 4% PFA, and blocked with 0.2% gelatin before incuba-
tion with primary antibodies ( -vinculin [Sigma-Aldrich];  -Raf-1 NH2 ter-
minus and  -Rok-  [BD Biosciences]) and staining with the appropriate
TRITC- or FITC-conjugated secondary antibodies (Molecular Probes). Rho-
damine-conjugated phalloidin (Molecular Probes) was used to visualize
actin filaments. To visualize vimentin intermediate filaments cells were ex-
tracted/fixed in methanol containing 5 mM EDTA and permeabilized with
0.5% Triton X-100. Cells were subsequently stained with an  -vimentin an-
tibody (Sigma-Aldrich) followed by TRITC-conjugated secondary antibod-
ies before mounting with ProLong Antifade (Promega). Epifluorescence
was performed using an Axioplan 2 microscope (Carl Zeiss MicroImag-
ing, Inc.) equipped with a Plan-Neofluar 40 /1.30 oil objective and a
CCD camera (Spot2; Diagnostic Instruments, Inc.). Images were acquired
using the MetaVue 5.0r6 software (Universal Imaging Corporation). Con-
focal microscopy was performed with a Axiovert 100M confocal micro-
scope (Carl Zeiss MicroImaging, Inc.) equipped with a Plan-Apochromat
63 /1.40 oil objective. The confocal images were acquired using the
LSM 510 2.3 software. The pictures show Z-stacks.
Rho pull down assay
The amount of active Rho present in migrating cells was determined by af-
finity chromatography on Rho binding domain of rhotekin immobilized on
agarose beads using the Rho activity assay kit (Upstate Biotechnology) ac-
cording to the manufacturer’s instructions. The amount of bound (active)
and total Rho was determined by immunoblotting.
ADP-ribosylation of Rho
Rho ADP-ribosylation was achieved by incubating fibroblasts for 3 h with
C. botulinum C2 toxin (C2IIa: 600 ng/ml; to enable uptake of the C3-like
exoenzyme) plus a fusion toxin (C2IN-C3: 300 ng/ml) consisting of the
NH2-terminal part of binding component of the C. botulinum C2 toxin
(C2IN) and the full-length C3-like ADP-ribosyltransferase from C. limosum
Ia toxin, as described previously (Barth et al., 1998; a gift from H. Barth
and K. Aktories, University of Freiburg, Freiburg, Germany).
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